Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 69 of 69 entries
View as:

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01256736 Org: User:
Start: 03/31/10 End: 11/30/13 Due: 11/30/14

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM

Phase: N/A Priority: Normal
NCT ID: NCT04267601 Org: User:
Start: 07/06/17 End: 09/30/21 Due: 09/30/22

The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04270344 Org: User:
Start: 07/01/18 End: 06/30/22 Due: 06/30/23

The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04805801 Org: User:
Start: 08/28/19 End: 02/28/25 Due: 02/28/26

Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT01402843 Org: User:
Start: 06/30/11 End: 01/31/13 Due: 01/31/14

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00889226 Org: User:
Start: 04/30/08 End: 01/31/10 Due: 01/31/11

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05351840 Org: User:
Start: 11/02/20 End: 01/15/21 Due: 01/15/22

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)

Phase: N/A Priority: Normal
NCT ID: NCT01259531 Org: User:
Start: 12/31/10 End: 09/30/11 Due: 09/30/12

Glufast On Insulin Glargine Trial in Type 2 DM

Phase: N/A Priority: Normal
NCT ID: NCT00663884 Org: User:
Start: 02/29/08 End: 09/30/09 Due: 09/30/10

Phase 1 Study(Additional) of URC102 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02524678 Org: User:
Start: 08/05/15 End: 03/28/16 Due: 03/28/17

Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT03055286 Org: User:
Start: 02/06/17 End: 10/31/22 Due: 10/31/23

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06665425 Org: User:
Start: 11/30/24 End: 02/28/25 Due: 02/28/26

MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04810507 Org: User:
Start: 11/09/18 End: 01/05/21 Due: 01/05/22

Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT04853992 Org: User:
Start: 05/10/21 End: 07/11/22 Due: 07/11/23

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01211834 Org: User:
Start: 10/31/09 End: 10/31/10 Due: 10/31/11

to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02056847 Org: User:
Start: 09/30/13 End: 05/31/17 Due: 05/31/18

Livalo Acute Myocardial Infarction Study

Phase: N/A Priority: Normal
NCT ID: NCT00805714 Org: User:
Start: 04/30/07 End: 03/31/11 Due: 03/31/12

A Trial to Evaluate the Effect of Food on LEO 152020

Phase: N/A Priority: Normal
NCT ID: NCT04203836 Org: User:
Start: 01/09/20 End: 12/12/20 Due: 12/12/21

Efficacy and Safety of Pitavastatin in a Real-world Setting

Phase: N/A Priority: Normal
NCT ID: NCT04402112 Org: User:
Start: 04/02/12 End: 08/01/17 Due: 08/01/18